These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 9055056

  • 41. The use of cardiac biomarkers in detection of cardiotoxicity associated with conventional and high-dose chemotherapy for acute leukemia.
    Horacek JM, Vasatova M, Tichy M, Pudil R, Jebavy L, Maly J.
    Exp Oncol; 2010 Jul; 32(2):97-9. PubMed ID: 20693970
    [Abstract] [Full Text] [Related]

  • 42. Cardiac troponin I and troponin T: recent players in the field of myocardial markers.
    Chapelle JP.
    Clin Chem Lab Med; 1999 Jan; 37(1):11-20. PubMed ID: 10094373
    [Abstract] [Full Text] [Related]

  • 43. Genetic and biochemical heterogeneity of cardiac troponins: clinical and laboratory implications.
    Lippi G, Targher G, Franchini M, Plebani M.
    Clin Chem Lab Med; 2009 Jan; 47(10):1183-94. PubMed ID: 19754353
    [Abstract] [Full Text] [Related]

  • 44. Immunoenzymometric assay of human glycogen phosphorylase isoenzyme BB in diagnosis of ischemic myocardial injury.
    Rabitzsch G, Mair J, Lechleitner P, Noll F, Hofmann U, Krause EG, Dienstl F, Puschendorf B.
    Clin Chem; 1995 Jul; 41(7):966-78. PubMed ID: 7600699
    [Abstract] [Full Text] [Related]

  • 45. Diseased skeletal muscle: a noncardiac source of increased circulating concentrations of cardiac troponin T.
    Jaffe AS, Vasile VC, Milone M, Saenger AK, Olson KN, Apple FS.
    J Am Coll Cardiol; 2011 Oct 18; 58(17):1819-24. PubMed ID: 21962825
    [Abstract] [Full Text] [Related]

  • 46. Clinical and experimental results on cardiac troponin expression in Duchenne muscular dystrophy.
    Hammerer-Lercher A, Erlacher P, Bittner R, Korinthenberg R, Skladal D, Sorichter S, Sperl W, Puschendorf B, Mair J.
    Clin Chem; 2001 Mar 18; 47(3):451-8. PubMed ID: 11238296
    [Abstract] [Full Text] [Related]

  • 47. The specificity of biochemical markers of cardiac damage: a problem solved.
    Apple FS.
    Clin Chem Lab Med; 1999 Mar 18; 37(11-12):1085-9. PubMed ID: 10726816
    [Abstract] [Full Text] [Related]

  • 48. Glycogen Phosphorylase BB: A more Sensitive and Specific Marker than Other Cardiac Markers for Early Diagnosis of Acute Myocardial Infarction.
    Singh N, Rathore V, Mahat RK, Rastogi P.
    Indian J Clin Biochem; 2018 Jul 18; 33(3):356-360. PubMed ID: 30072837
    [Abstract] [Full Text] [Related]

  • 49. Influence of acute physical exercise on emerging muscular biomarkers.
    Lippi G, Schena F, Montagnana M, Salvagno GL, Guidi GC.
    Clin Chem Lab Med; 2008 Jul 18; 46(9):1313-8. PubMed ID: 18636795
    [Abstract] [Full Text] [Related]

  • 50. Noninvasive assessment of myocardial cell injury in dogs with suspected cardiac contusion.
    Schober KE, Kirbach B, Oechtering G.
    J Vet Cardiol; 1999 Dec 18; 1(2):17-25. PubMed ID: 19081322
    [Abstract] [Full Text] [Related]

  • 51. [Multi-marker approach in the diagnostics of cardiac diseases by protein biochip technology].
    Vasatová M, Tichý M, Horácek JM, Pudil R, Horáková L, Palicka V.
    Cas Lek Cesk; 2009 Dec 18; 148(12):591-6. PubMed ID: 20662394
    [Abstract] [Full Text] [Related]

  • 52. Glycogen phosphorylase isoenzyme BB to diagnose ischaemic myocardial damage.
    Mair J.
    Clin Chim Acta; 1998 Apr 06; 272(1):79-86. PubMed ID: 9581859
    [Abstract] [Full Text] [Related]

  • 53. Biomarker panel of cardiac and skeletal muscle troponins, fatty acid binding protein 3 and myosin light chain 3 for the accurate diagnosis of cardiotoxicity and musculoskeletal toxicity in rats.
    Tonomura Y, Matsushima S, Kashiwagi E, Fujisawa K, Takagi S, Nishimura Y, Fukushima R, Torii M, Matsubara M.
    Toxicology; 2012 Dec 16; 302(2-3):179-89. PubMed ID: 22878004
    [Abstract] [Full Text] [Related]

  • 54. Biochemical markers of myocardial damage.
    Bhayana V, Henderson AR.
    Clin Biochem; 1995 Feb 16; 28(1):1-29. PubMed ID: 7720223
    [Abstract] [Full Text] [Related]

  • 55. Glycogen phosphorylase BB in myocardial infarction.
    Dobric M, Ostojic M, Giga V, Djordjevic-Dikic A, Stepanovic J, Radovanovic N, Beleslin B.
    Clin Chim Acta; 2015 Jan 01; 438():107-11. PubMed ID: 25139494
    [Abstract] [Full Text] [Related]

  • 56. The Diagnostic Value of Plasma miRNA-497, cTnI, FABP3 and GPBB in Pediatric Sepsis Complicated with Myocardial Injury.
    Huang C, Xiao S, Xia Z, Cheng Y, Li Y, Tang W, Shi B, Qin C, Xu H.
    Ther Clin Risk Manag; 2021 Jan 01; 17():563-570. PubMed ID: 34113113
    [Abstract] [Full Text] [Related]

  • 57. Biomarker evaluation of skeletal muscle toxicity following clofibrate administration in rats.
    Bodié K, Buck WR, Pieh J, Liguori MJ, Popp A.
    Exp Toxicol Pathol; 2016 May 01; 68(5):289-99. PubMed ID: 27020044
    [Abstract] [Full Text] [Related]

  • 58. Glycogen phosphorylase isoenzyme BB in diagnosis of myocardial ischaemic injury and infarction.
    Krause EG, Rabitzsch G, Noll F, Mair J, Puschendorf B.
    Mol Cell Biochem; 1996 May 01; 160-161():289-95. PubMed ID: 8901485
    [Abstract] [Full Text] [Related]

  • 59. A serial follow up study of cardiac marker enzymes during the week after acute myocardial infarction.
    Shah H, Haridas N.
    Indian J Clin Biochem; 2007 Mar 01; 22(1):33-6. PubMed ID: 23105649
    [Abstract] [Full Text] [Related]

  • 60. Acute myocardial injury secondary to severe acute liver failure: A retrospective analysis supported by animal data.
    Uhlig M, Hein M, Habigt MA, Tolba RH, Braunschweig T, Helmedag MJ, Klinge U, Koch A, Trautwein C, Mechelinck M.
    PLoS One; 2021 Mar 01; 16(8):e0256790. PubMed ID: 34460845
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.